Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    This Biotech Startup Just Scored a Key Cancer Breakthrough

    Don't worry if you've never heard of Robert Langer. Few investors have.

    But 20 years from now, when some enterprising author writes the book about how the United States finally found a cure for cancer, you can bet that Langer will be there, front and center, in the table of contents, or maybe even on the cover.

    Today Langer is a distinguished professor at MIT, in chemical and biomedical engineering. More importantly for investors like us, he is the co-founder of a hot biotech startup that just reported a key cancer breakthrough.

    It's called BIND Biosciences. And it isn't just on an IPO track.

    It's one of the companies I refer to when I say technology can save America. Thanks to this nation's innovative thinkers and savvy entrepreneurs, just like Langer, this country leads the world in high-tech breakthroughs - the kind that reshape lives and histories. And that's what makes me truly believe that The Land of Opportunity is bound to come out ahead in the long run.

    So if you want to make big money in the Era of Radical Change, you can forget about the global debt crisis. Ditto Washington's antics. Same goes for monthly jobs reports and even the market's ups and downs.

    You need to keep an eye on guys like Bob Langer.

    Here's why...

    His Team Has Given Millions New Reason for Hope

    Right now 12 million Americans are suffering from some form of cancer; the disease will kill one-third of them outright. In the next 24 hours, nearly 1,500 cancer patients will die. Odds are, several people will have passed away by the time you read this report.

    Many of you will relate to this on a personal level. I know I do. Cancer killed my maternal grandmother and two of my friends.

    Yet today, finally, after many billions of dollars funneled into cancer research over the decades, I believe we have passed the "tipping point" in our long battle against this deadly disease. I predict that within a decade we will cut the number of cancer deaths in half.

    Not only will sharp biotech investors (like us) profit along the way, the nation as a whole will get a tremendous payoff when that happens. After all, cancer costs the U.S. roughly $225 billion a year in health-care bills and lost wages.

    So, the Langer team's breakthrough has much to offer America, at a time when many people fear that China is getting ready to have us for lunch. Well, let me tell you this. You won't see this kind of innovation coming out of China any time soon.

    Here's How They Did It

    As it turns out, Langer's team used very small - but very mighty - weapons to fight the cancer war.


    To continue reading, please click here...
    Read More...
  • bind biosciences news